These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombinant clotting factors in the treatment of hemophilia. Lee C Thromb Haemost; 1999 Aug; 82(2):516-24. PubMed ID: 10605745 [No Abstract] [Full Text] [Related]
3. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR; Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203 [No Abstract] [Full Text] [Related]
4. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192 [TBL] [Abstract][Full Text] [Related]
5. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada. CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466 [TBL] [Abstract][Full Text] [Related]
6. Key issues in inhibitor management in patients with haemophilia. Gomez K; Klamroth R; Mahlangu J; Mancuso ME; Mingot ME; Ozelo MC Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s319-29. PubMed ID: 24333092 [No Abstract] [Full Text] [Related]
7. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Hedner U Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747 [No Abstract] [Full Text] [Related]
8. Will recent innovations in therapy save perceived deficiencies in self-sufficiency policies. Limentani SA Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S81-4. PubMed ID: 7795145 [TBL] [Abstract][Full Text] [Related]
9. Lupus anticoagulants associated inhibitor against factor IX in a young patient with haemophilia B. Barnbrock A; Heller C; Königs C; Budde U; Schwabe D Haemophilia; 2016 Sep; 22(5):e437-9. PubMed ID: 27353656 [No Abstract] [Full Text] [Related]
10. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors. Young G; McDaniel M; Nugent DJ Haemophilia; 2005 May; 11(3):203-7. PubMed ID: 15876264 [TBL] [Abstract][Full Text] [Related]
11. Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe haemophilia B. Hewson ID; Makhmaloaf P Aust Dent J; 2010 Sep; 55(3):322-4. PubMed ID: 20887522 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in the management of haemophilia and christmas disease. Biggs R Clin Haematol; 1979 Feb; 8(1):95-114. PubMed ID: 367667 [No Abstract] [Full Text] [Related]
13. The evolution of recombinant factor replacement for hemophilia. Sankar AD; Weyand AC; Pipe SW Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983 [TBL] [Abstract][Full Text] [Related]
14. Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registries. Shapiro AD; Neufeld EJ; Blanchette V; Salaj P; Gut RZ; Cooper DL Haemophilia; 2014 Jan; 20(1):e23-31. PubMed ID: 24354484 [TBL] [Abstract][Full Text] [Related]
15. EHL-FIX in haemophilia B carriers with FIX deficiency. Marlière C; Maindiaux L; Lambert C; Hermans C Haemophilia; 2020 Mar; 26(2):e38-e40. PubMed ID: 31840356 [No Abstract] [Full Text] [Related]
16. Safety of the new generation recombinant factor concentrates. Schlesinger KW; Ragni MV Expert Opin Drug Saf; 2002 Sep; 1(3):213-23. PubMed ID: 12904137 [TBL] [Abstract][Full Text] [Related]
17. The challenge arising from the cost of haemophilia care: an audit of haemophilia treatment at Auckland Hospital. Harper P; Brasser M; Moore L; Teague L; Pitcher L; Ockelford P N Z Med J; 2003 Aug; 116(1180):U561. PubMed ID: 14581983 [TBL] [Abstract][Full Text] [Related]
18. Some recent developments regarding arthropathy and inhibitors in haemophilia. Rodriguez-Merchan EC Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189 [TBL] [Abstract][Full Text] [Related]
19. [Haemophilia]. Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381 [TBL] [Abstract][Full Text] [Related]